Form 8-K - Current report:
SEC Accession No. 0001157523-09-006426
Filing Date
2009-09-10
Accepted
2009-09-10 16:07:54
Documents
24
Period of Report
2009-09-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ORE PHARMACEUTICALS INC. 8-K a6046985.htm 8-K 14553
2 EXHIBIT 99.1 a6046985ex99_1.htm EX-99.1 36871
3 slide1.jpg GRAPHIC 23761
4 slide2.jpg GRAPHIC 60381
5 slide3.jpg GRAPHIC 34044
6 slide4.jpg GRAPHIC 40717
7 slide5.jpg GRAPHIC 39085
8 slide6.jpg GRAPHIC 29090
9 slide7.jpg GRAPHIC 43986
10 slide8.jpg GRAPHIC 35027
11 slide9.jpg GRAPHIC 39253
12 slide10.jpg GRAPHIC 45704
13 slide11.jpg GRAPHIC 35192
14 slide12.jpg GRAPHIC 50659
15 slide13.jpg GRAPHIC 38059
16 slide14.jpg GRAPHIC 52054
17 slide15.jpg GRAPHIC 42083
18 slide16.jpg GRAPHIC 31394
19 slide17.jpg GRAPHIC 20579
20 slide18.jpg GRAPHIC 40446
21 slide19.jpg GRAPHIC 37462
22 slide20.jpg GRAPHIC 28326
23 slide21.jpg GRAPHIC 34860
24 slide22.jpg GRAPHIC 81381
  Complete submission text file 0001157523-09-006426.txt   1272942
Mailing Address 610 PROFESSIONAL DRIVE SUITE 101 GAITHERSBURG MD 20879
Business Address 610 PROFESSIONAL DRIVE SUITE 101 GAITHERSBURG MD 20879 2403614400
ORE PHARMACEUTICALS INC. (Filer) CIK: 0001043914 (see all company filings)

EIN.: 061411336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23317 | Film No.: 091062945
SIC: 2835 In Vitro & In Vivo Diagnostic Substances